KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Profit After Tax Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.02%
Dec 31, 2025 -3.77%
Sep 30, 2025 9.74%
Jun 30, 2025 -4.50%
Mar 31, 2025 -1.06%
Dec 31, 2024 -18.11%
Sep 30, 2024 7.54%
Jun 30, 2024 -19.30%
Mar 31, 2024 -15.51%
Dec 31, 2023 -16.84%
Sep 30, 2023 -1.43%
Jun 30, 2023 -9.69%
Mar 31, 2023 4.22%
Dec 31, 2022 18.93%
Sep 30, 2022 1.18%
Jun 30, 2022 -9.35%
Mar 31, 2022 -6.55%
Dec 31, 2021 -0.37%
Sep 30, 2021 -1.36%
Jun 30, 2021 -24.33%
Mar 31, 2021 -2.83%
Dec 31, 2020 -2.15%
Sep 30, 2020 1.64%
Jun 30, 2020 1.75%
Mar 31, 2020 2.37%
Dec 31, 2019 5.65%
Sep 30, 2019 9.61%
Jun 30, 2019 7.09%
Mar 31, 2019 13.17%
Dec 31, 2018 13.56%
Sep 30, 2018 6.33%
Jun 30, 2018 12.79%
Mar 31, 2018 10.01%
Dec 31, 2017 -49.27%
Sep 30, 2017 12.79%
Jun 30, 2017 11.18%
Mar 31, 2017 11.83%
Dec 31, 2016 15.68%
Sep 30, 2016 34.75%
Jun 30, 2016 9.83%
Mar 31, 2016 11.05%
Dec 31, 2015 11.99%
Sep 30, 2015 8.55%
Jun 30, 2015 6.58%
Mar 31, 2015 6.82%
Dec 31, 2014 6.81%
Sep 30, 2014 -2.14%
Jun 30, 2014 4.04%
Mar 31, 2014 1.04%